{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T19:49:02Z","timestamp":1721677742986},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T00:00:00Z","timestamp":1236124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00228-009-0633-8","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T06:16:24Z","timestamp":1236060984000},"page":"685-691","source":"Crossref","is-referenced-by-count":12,"title":["Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder"],"prefix":"10.1007","volume":"65","author":[{"given":"Yoshinori","family":"Saeki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikito","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genta","family":"Hirokane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutaka","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,4]]},"reference":[{"key":"633_CR1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archpsyc.1997.01830160021003","volume":"54","author":"MM Weissman","year":"1997","unstructured":"Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK (1997) The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54:305\u2013309","journal-title":"Arch Gen Psychiatry"},{"key":"633_CR2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00127-002-0542-y","volume":"37","author":"P Carlbring","year":"2002","unstructured":"Carlbring P, Gustafsson H, Ekselius L, Andersson G (2002) 12-month prevalence of panic disorder with or without agoraphobia in the Swedish general population. Soc Psychiatry Psychiatr Epidemiol 37:207\u2013211","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"633_CR3","doi-asserted-by":"crossref","first-page":"065","DOI":"10.1001\/archpsyc.1983.01790090027004","volume":"40","author":"RR Crowe","year":"1983","unstructured":"Crowe RR, Noyes R, Pauls DL, Slymen D (1983) A family study of panic disorder. Arch Gen Psychiatry 40:065\u20131069","journal-title":"Arch Gen Psychiatry"},{"key":"633_CR4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.1983.01790090023003","volume":"40","author":"EL Harris","year":"1983","unstructured":"Harris EL, Noyes R Jr, Crowe RR, Chaudhry DR (1983) Family study of agoraphobia. Report of a pilot study. Arch Gen Psychiatry 40:1061\u20131064","journal-title":"Arch Gen Psychiatry"},{"key":"633_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1600-0447.1993.tb03419.x","volume":"88","author":"I Skre","year":"1993","unstructured":"Skre I, Onstad S, Torgersen S, Lygren S, Kringlen E (1993) A twin study of DSM-III-R anxiety disorders. Acta Psychiatr Scand 88:85\u201392","journal-title":"Acta Psychiatr Scand"},{"key":"633_CR6","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/appi.ajp.158.10.1568","volume":"158","author":"JM Hettema","year":"2001","unstructured":"Hettema JM, Neale MC, Kendler KS (2001) A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158:1568\u20131578","journal-title":"Am J Psychiatry"},{"key":"633_CR7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1192\/bjp.167.3.374","volume":"167","author":"S Oehrberg","year":"1995","unstructured":"Oehrberg S, Christiansen PE, Behnke K, Borup AL, Severin B, Soegaard J, Calberg H, Judge R, Ohrstrom JK, Manniche PM (1995) Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. Br J Psychiatry 167:374\u2013379","journal-title":"Br J Psychiatry"},{"key":"633_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0447.1997.tb00388.x","volume":"95","author":"Y Lecrubier","year":"1997","unstructured":"Lecrubier Y, Bakker A, Dunbar G, Judge R (1997) A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand 95:145\u2013152","journal-title":"Acta Psychiatr Scand"},{"key":"633_CR9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0447.1997.tb00389.x","volume":"95","author":"Y Lecrubier","year":"1997","unstructured":"Lecrubier Y, Judge R (1997) Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand 95:153\u2013160","journal-title":"Acta Psychiatr Scand"},{"key":"633_CR10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1176\/ajp.155.1.36","volume":"155","author":"JC Ballenger","year":"1998","unstructured":"Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP (1998) Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry 155:36\u201342","journal-title":"Am J Psychiatry"},{"key":"633_CR11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archpsyc.1993.01820130046008","volume":"50","author":"DW Black","year":"1993","unstructured":"Black DW, Wesner R, Bowers W, Gabel J (1993) A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 50:44\u201350","journal-title":"Arch Gen Psychiatry"},{"key":"633_CR12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-2007-979311","volume":"31","author":"J Sandmann","year":"1998","unstructured":"Sandmann J, Lorch B, Bandelow B, Hartter S, Winter P, Hiemke C, Benkert O (1998) Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine. Pharmacopsychiatry 31:117\u2013121","journal-title":"Pharmacopsychiatry"},{"key":"633_CR13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/FTD.0b013e31802bb194","volume":"29","author":"T Watanabe","year":"2007","unstructured":"Watanabe T, Ueda M, Saeki Y, Hirokane G, Morita S, Okawa M, Akiyama K, Shimoda K (2007) High plasma concentrations of paroxetine impede clinical response in patients with panic disorder. Ther Drug Monit 29:40\u201344","journal-title":"Ther Drug Monit"},{"key":"633_CR14","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1176\/appi.ajp.158.11.1843","volume":"158","author":"JH Meyer","year":"2001","unstructured":"Meyer JH, Wilson AA, Ginovart N, Goulding V, Hussey D, Hood K, Houle S (2001) Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry 158:1843\u20131849","journal-title":"Am J Psychiatry"},{"key":"633_CR15","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1126\/science.274.5292.1527","volume":"274","author":"KP Lesch","year":"1996","unstructured":"Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527\u20131531","journal-title":"Science"},{"key":"633_CR16","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1046\/j.1471-4159.1996.66062621.x","volume":"66","author":"A Heils","year":"1996","unstructured":"Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621\u20132624","journal-title":"J Neurochem"},{"key":"633_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00041444-199700710-00008","volume":"7","author":"J Deckert","year":"1997","unstructured":"Deckert J, Catalano M, Heils A, Di Bella D, Friess F, Politi E, Franke P, Nothen MM, Maier W, Bellodi L, Lesch KP (1997) Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr Genet 7:45\u201347","journal-title":"Psychiatr Genet"},{"key":"633_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00041444-199903000-00001","volume":"9","author":"SP Hamilton","year":"1999","unstructured":"Hamilton SP, Heiman GA, Haghighi F, Mick S, Klein DF, Hodge SE, Weissman MM, Fyer AJ, Knowles JA (1999) Lack of genetic linkage or association between a functional serotonin transporter polymorphism and panic disorder. Psychiatr Genet 9:1\u20136","journal-title":"Psychiatr Genet"},{"key":"633_CR19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1440-1819.1997.tb03208.x","volume":"51","author":"H Ishiguro","year":"1997","unstructured":"Ishiguro H, Arinami T, Yamada K, Otsuka Y, Toru M, Shibuya H (1997) An association study between a transcriptional polymorphism in the serotonin transporter gene and panic disorder in a Japanese population. Psychiatry Clin Neurosci 51:333\u2013335","journal-title":"Psychiatry Clin Neurosci"},{"key":"633_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00041444-200509000-00003","volume":"15","author":"OF Olesen","year":"2005","unstructured":"Olesen OF, Bennike B, Hansen ES, Koefoed P, Woldbye DP, Bolwig TG, Mellerup E (2005) The short\/long polymorphism in the serotonin transporter gene promoter is not associated with panic disorder in a Scandinavian sample. Psychiatr Genet 15:159","journal-title":"Psychiatr Genet"},{"key":"633_CR21","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/sj.npp.1300822","volume":"30","author":"G Perna","year":"2005","unstructured":"Perna G, Favaron E, Di Bella D, Bussi R, Bellodi L (2005) Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology 30:2230\u20132235","journal-title":"Neuropsychopharmacology"},{"key":"633_CR22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00004850-199506000-00003","volume":"10","author":"B Bandelow","year":"1995","unstructured":"Bandelow B (1995) Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Int Clin Psychopharmacol 10:73\u201381","journal-title":"Int Clin Psychopharmacol"},{"key":"633_CR23","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/00007691-200312000-00014","volume":"25","author":"C Charlier","year":"2003","unstructured":"Charlier C, Broly F, Lhermitte M, Pinto E, Ansseau M, Plomteux G (2003) Polymorphisms in the CYP 2D6 gene: association with plasma concentrations of fluoxetine and paroxetine. Ther Drug Monit 25:738\u2013742","journal-title":"Ther Drug Monit"},{"key":"633_CR24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4088\/JCP.v61n0810b","volume":"61","author":"C G\u00fczey","year":"2000","unstructured":"G\u00fczey C, Aamo T, Spigset O (2000) Risperidone metabolism and the impact of being a cytochrome P450 2D6 ultrarapid metabolizer. J Clin Psychiatry 61:600\u2013601","journal-title":"J Clin Psychiatry"},{"key":"633_CR25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00008571-200008000-00010","volume":"10","author":"Y Nishida","year":"2000","unstructured":"Nishida Y, Fukuda T, Yamamoto I, Azuma J (2000) CYP2D6 genotypes in a Japanese population: low frequencies of CYP2D6 gene duplication but high frequency of CYP2D6*10. Pharmacogenetics 10:567\u2013570","journal-title":"Pharmacogenetics"},{"key":"633_CR26","first-page":"354","volume":"19","author":"K Hikida","year":"1990","unstructured":"Hikida K, Inoue Y, Nouchi E, Ohkura Y (1990) Determination of etizolam in human serum or plasma using automated column-switching high-performance liquid chromatography. Jpn J Clin Chem 19:354\u2013359","journal-title":"Jpn J Clin Chem"},{"key":"633_CR27","volume-title":"Essential psychopharmacology","author":"SM Stahl","year":"2000","unstructured":"Stahl SM (2000) Essential psychopharmacology, 2nd ed. Cambridge University Press, New York","edition":"2"},{"key":"633_CR28","first-page":"435","volume":"54","author":"AK Louie","year":"1993","unstructured":"Louie AK, Lewis TB, Lannon RA (1993) Use of low-dose fluoxetine in major depression and panic disorder. J Clin Psychiatry 54:435\u2013438","journal-title":"J Clin Psychiatry"},{"key":"633_CR29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-2005-864121","volume":"38","author":"M Gilles","year":"2005","unstructured":"Gilles M, Deuschle M, Kellner S, Shams M, Krumm B, Hartter S, Heuser I, Hiemke C (2005) Paroxetine serum concentrations in depressed patients and response to treatment. Pharmacopsychiatry 38:118\u2013121","journal-title":"Pharmacopsychiatry"},{"key":"633_CR30","doi-asserted-by":"crossref","first-page":"854","DOI":"10.4088\/JCP.v63n1001","volume":"63","author":"SM Stahl","year":"2002","unstructured":"Stahl SM (2002) Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents. J Clin Psychiatry 63:854\u2013855","journal-title":"J Clin Psychiatry"},{"key":"633_CR31","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1523\/JNEUROSCI.3769-04.2005","volume":"25","author":"SP David","year":"2005","unstructured":"David SP, Murthy NV, Rabiner EA, Munafo MR, Johnstone EC, Jacob R, Walton RT, Grasby PM (2005) A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 25:2586\u20132590","journal-title":"J Neurosci"},{"issue":"Suppl 4","key":"633_CR32","first-page":"8","volume":"66","author":"NM Simon","year":"2005","unstructured":"Simon NM, Fischmann D (2005) The implications of medical and psychiatric comorbidity with panic disorder. J Clin Psychiatry 66(Suppl 4):8\u201315","journal-title":"J Clin Psychiatry"},{"key":"633_CR33","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/archpsyc.61.11.1163","volume":"61","author":"GM Murphy Jr","year":"2004","unstructured":"Murphy GM Jr, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF (2004) Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry 61:1163\u20131169","journal-title":"Arch Gen Psychiatry"},{"key":"633_CR34","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0006-3223(03)00424-4","volume":"54","author":"RH Perlis","year":"2003","unstructured":"Perlis RH, Mischoulon D, Smoller JW, Wan YJ, Lamon-Fava S, Lin KM, Rosenbaum JF, Fava M (2003) Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry 54:879\u2013883","journal-title":"Biol Psychiatry"},{"key":"633_CR35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0924-977X(02)00056-1","volume":"12","author":"H Takahashi","year":"2002","unstructured":"Takahashi H, Yoshida K, Ito K, Sato K, Kamata M, Higuchi H, Shimizu T, Ito K, Inoue K, Tezuka T, Suzuki T, Ohkubo T, Sugawara K (2002) No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment. Eur Neuropsychopharmacol 12:477\u2013481","journal-title":"Eur Neuropsychopharmacol"},{"key":"633_CR36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000094727","volume":"53","author":"M Kato","year":"2006","unstructured":"Kato M, Fukuda T, Wakeno M, Fukuda K, Okugawa G, Ikenaga Y, Yamashita M, Takekita Y, Nobuhara K, Azuma J, Kinoshita T (2006) Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. Neuropsychobiology 53:186\u2013195","journal-title":"Neuropsychobiology"},{"key":"633_CR37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1744-9081-3-41","volume":"3","author":"C Blaya","year":"2007","unstructured":"Blaya C, Salum GA, Lima MS, Leistner-Segal S, Manfro GG (2007) Lack of association between the serotonin transporter promoter polymorphism (5-HTTLPR) and panic disorder: a systematic review and meta-analysis. Behav Brain Funct 3:41. doi: 10.1186\/1744\u20139081\u20133\u201341","journal-title":"Behav Brain Funct"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-009-0633-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-009-0633-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-009-0633-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:51:57Z","timestamp":1558702317000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-009-0633-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,4]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["633"],"URL":"https:\/\/doi.org\/10.1007\/s00228-009-0633-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,4]]}}}